Form 4: Agilent Director Boosts Stake with Share Acquisition

Agilent Technologies Director Dow R. Wilson acquired 2,158 shares of common stock at $111.75 per share, increasing his beneficial ownership.

Summary

• Dow R. Wilson, a Director of Agilent Technologies, Inc. (A), acquired 2,158 shares of common stock.
• The acquisition occurred on March 19, 2026, at a price of $111.75 per share.
• These shares were part of an award for Non-Employee Directors and were fully vested upon grant.
• An additional 144.124 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan and deferred.
• Following these transactions, Mr. Wilson's total beneficial ownership stands at 20,368.606 shares of Agilent common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director's acquisition of shares, even through an award and DRIP, generally indicates confidence in the company's performance and future value.

Positives

• A Director increasing their stake in the company can signal confidence in future performance.
• The acquisition of shares through a director award and dividend reinvestment plan demonstrates ongoing participation and alignment with shareholder interests.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider buying, particularly by a director, can be interpreted by the market as a positive signal, suggesting that those closest to the company believe its stock is undervalued or poised for growth. This transaction occurs within the broader context of the life sciences and diagnostics industry, where Agilent Technologies operates, and reflects a director's ongoing compensation and investment strategy.

Comparison to Industry Standards

• StockSavvy.ai observes that director compensation often includes equity awards, similar to the 2,158 shares granted to Dow R. Wilson, aligning executive interests with shareholder value.
• Dividend reinvestment plans (DRIPs) are a common mechanism for long-term investors and insiders to incrementally increase their holdings, as seen with the 144.124 shares acquired by Mr. Wilson, reflecting a standard practice for compounding returns.
• While specific comparable companies or projects are not detailed in this Form 4, the general practice of directors increasing their stake through awards and DRIPs is consistent across many publicly traded companies, such as Thermo Fisher Scientific or Danaher Corporation, which also operate in related life sciences sectors and utilize similar compensation and investment structures for their leadership.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by Dow R. Wilson, a Director of Agilent Technologies, Inc., constitutes a related party transaction as it involves an insider of the company.

Stakeholder Impact

• Shareholders: Increased insider ownership may be viewed positively, signaling management's alignment with shareholder interests and confidence in the company's future.

Key Dates

Recommendation

While the director's acquisition of shares is a positive signal of confidence, a single Form 4 filing typically does not provide enough comprehensive information to warrant a "buy" or "strong buy" recommendation. It reinforces a "hold" position for existing investors, suggesting continued confidence, but does not present new fundamental data to significantly alter an investment thesis.

Keywords

Agilent Technologies, A, Dow R. Wilson, Form 4, Insider Trading, Share Acquisition, Director Stock Award, Dividend Reinvestment Plan, Beneficial Ownership